The big thing with axsm was it was 2b top line as well and soon followed with additional trials and fast tracking as we could see too. I really like CTAD being in early December. Last year it was in October and if the calendar was the same we might have been rushed to have results ready. No worries now. The fact its our second 2b trial adds credence as well imo.
Market Data 
Markets 
AI
